CleanCore Solutions (ZONE) 10-K 20 Sep 24 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Jun. 30, 2024	Sep. 19, 2024	Dec. 29, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Financial Statement Error Correction [Flag]	false
Entity Interactive Data Current	Yes
ICFR Auditor Attestation Flag	false
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Documents Incorporated by Reference [Text Block]	None
Entity Information [Line Items]
Entity Registrant Name	CleanCore Solutions, Inc.
Entity Central Index Key	0001956741
Entity File Number	001-42033
Entity Tax Identification Number	88-4042082
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Public Float			$ 2,545,824
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	5920 S 118th Circle
Entity Address, City or Town	Omaha
Entity Address, Country	NE
Entity Address, Postal Zip Code	68137
Entity Phone Fax Numbers [Line Items]
City Area Code	(877)
Local Phone Number	860-3030
Entity Listings [Line Items]
Title of 12(b) Security	Class B Common Stock, par value $0.0001 per share
Trading Symbol	ZONE
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		7,965,919

Audit Information

Audit Information	12 Months Ended
	Jun. 30, 2024
Auditor [Table]
Auditor Name	TAAD LLP
Auditor Firm ID	5854
Auditor Location	Diamond Bar, CA

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Current assets:
Cash and cash equivalents	$ 2,016,611	$ 393,194
Accounts receivable, net	467,286	233,560
Inventory, net	672,326	672,116
Deferred offering costs		302,755
Prepaid expenses and other current assets	55,365	135,666
Total current assets	3,211,588	1,737,291
Property and equipment, net	10,572	1,197
Right of use assets	524,818	466,661
Intangibles, net	1,486,923	1,640,919
Goodwill	2,237,910	2,237,910
Other assets	9,440	9,440
Total assets	7,481,251	6,093,418
Current liabilities:
Accounts payable and accrued expenses	573,956	644,627
Deferred revenue	10,395
Lease liability - current	131,887	87,985
Note payable - current	698,149	2,994,750
Total current liabilities	1,505,506	3,948,664
Lease liability – non current	418,104	398,540
Note payable – non current	1,821,184
Total liabilities	3,744,794	4,347,204
Commitments and contingencies (Note 16)
Stockholders’ Equity
Series Seed Preferred Stock, $0.001 par value, 4,000,000 shares authorized; 0 and 4,000,000 shares issued and outstanding as of June 30, 2024 and 2023, respectively		400
Additional paid-in capital	11,040,583	6,768,775
Accumulated deficit	(7,304,949)	(5,023,207)
Total stockholders’ equity	3,736,457	1,746,214
Total liabilities and stockholders’ equity	7,481,251	6,093,418
Related Party
Current liabilities:
Due to related parties	91,119	221,302
Class A Common Stock
Stockholders’ Equity
Common stock value	27	66
Class B Common Stock
Stockholders’ Equity
Common stock value	$ 796	$ 180

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2024	Jun. 30, 2023
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	0	4,000,000
Preferred stock, shares outstanding	0	4,000,000
Class A Common Stock
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	270,000	660,000
Common stock, shares outstanding	270,000	660,000
Class B Common Stock
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	7,960,919	1,795,940
Common stock, shares outstanding	7,960,919	1,795,940

Statements of Operations

Statements of Operations - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024
Revenue, net	$ 502,990	$ 1,938,366	$ 1,604,973
Cost of sales (exclusive of depreciation shown separately below)	351,740	1,359,401	809,161
Gross profit	151,250	578,965	795,812
Operating expenses:
General and administrative	334,535	5,310,961	2,471,480
Advertising expense	4,621	14,944	116,007
Depreciation and amortization expense	6,420	109,144	155,059
Loss from operations	(194,326)	(4,856,084)	(1,946,734)
Interest expense	125,738	167,123	335,008
Net income (loss)	$ (320,064)	$ (5,023,207)	$ (2,281,742)
Class A and Class B Stock
Operating expenses:
Net loss per share of Class A and Class B stock, basic (in Dollars per share)		$ (2.18)	$ (0.49)
Class A Common Stock
Operating expenses:
Net loss per share of Class A and Class B stock, basic (in Dollars per share)			$ (0.49)
Weighted average shares used in computing net loss per share, basic (in Shares)		967,987	350,192
Class B Common Stock
Operating expenses:
Net loss per share of Class A and Class B stock, basic (in Dollars per share)			$ (0.49)
Weighted average shares used in computing net loss per share, basic (in Shares)		1,334,414	4,311,142

Statements of Operations (Paren

Statements of Operations (Parentheticals) - $ / shares	8 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024
Class A and Class B stock
Net loss per share of Class A and Class B stock, diluted (in Dollars per share)	$ (2.18)	$ (0.49)
Class A Common Stock
Net loss per share of Class A and Class B stock, diluted (in Dollars per share)		$ (0.49)
Weighted average shares used in computing net loss per share, diluted	967,987	350,192
Class B Common Stock
Net loss per share of Class A and Class B stock, diluted (in Dollars per share)		$ (0.49)
Weighted average shares used in computing net loss per share, diluted	1,334,414	4,311,142

Statements of Stockholders_ Equ

Statements of Stockholders’ Equity (Deficit) - USD ($)	Preferred Stock Series Seed	Common Stock Class A	Common Stock Class B	Common Stock	Additional Paid in Capital	Members’ Capital Amount	Accumulated Deficit	Total
Balance at Jun. 30, 2022						$ 2,215,916	$ (8,224,933)	$ (6,009,017)
Balance (in Shares) at Jun. 30, 2022
Imputed interest						125,728		125,728
Net loss for the period							(320,064)	(320,064)
Balance at Oct. 16, 2022						2,341,644	(8,544,997)	(6,203,353)
Balance (in Shares) at Oct. 16, 2022
Balance at Jun. 30, 2022						2,215,916	(8,224,933)	$ (6,009,017)
Balance (in Shares) at Jun. 30, 2022
Issuance of class B common stock upon exercise of warrants (in Shares)
Balance at Jun. 30, 2023	$ 400	$ 66	$ 180		6,768,775		(5,023,207)	$ 1,746,214
Balance (in Shares) at Jun. 30, 2023	4,000,000	660,000	1,795,940
Balance at Oct. 16, 2022						2,341,644	(8,544,997)	(6,203,353)
Balance (in Shares) at Oct. 16, 2022
Issuance of series seed preferred stock	$ 400				999,600			1,000,000
Issuance of series seed preferred stock (in Shares)	4,000,000
Issuance of class A common stock		$ 100						100
Issuance of class A common stock (in Shares)		1,000,000
Issuance of class B common stock			$ 66		1,152,156			1,152,222
Issuance of class B common stock (in Shares)			660,921
Conversion of class A common stock into class B common stock		$ (34)	$ 34
Conversion of class A common stock into class B common stock (in Shares)		(340,000)	340,000
Issuance of class B common stock upon exercise of warrants			$ 78		497,700			497,778
Issuance of class B common stock upon exercise of warrants (in Shares)			777,778
Warrants issued to consultants for services					857,889			857,889
Stock based compensation – officers					3,082,000			3,082,000
Stock based compensation – third party			$ 2		29,997			29,999
Stock based compensation – third party (in Shares)			17,241
Sock based compensation - 2022 Equity Incentive Plan					149,433			149,433
Net loss for the period							(5,023,207)	(5,023,207)
Balance at Jun. 30, 2023	$ 400	$ 66	$ 180		6,768,775		(5,023,207)	1,746,214
Balance (in Shares) at Jun. 30, 2023	4,000,000	660,000	1,795,940
Conversion of class A common stock into class B common stock		$ (439)	$ 439
Conversion of class A common stock into class B common stock (in Shares)		(4,390,000)	4,390,000	4,000,000
Conversion of series seed preferred stock into class A common stock	$ (400)	$ 400
Conversion of series seed preferred stock into class A common stock (in Shares)	(4,000,000)	4,000,000
Issuance of class B common stock pursuant to initial public offering, net of issuance and deferred offering costs of $1,656,453			$ 125		3,343,422			3,343,547
Issuance of class B common stock pursuant to initial public offering, net of issuance and deferred offering costs of $1,656,453 (in Shares)			1,250,000
Issuance of common stock pursuant to convertible notes			$ 25		257,455			257,480
Issuance of common stock pursuant to convertible notes (in Shares)			257,479
Issuance of Non-qualified stock options					126,975			126,975
Issuance of restrictive stock units			$ 9		320,017			320,026
Issuance of restrictive stock units (in Shares)			92,500
Issuance of restrictive stock awards			$ 18		51,086			$ 51,104
Issuance of restrictive stock awards (in Shares)			175,000
Issuance of class B common stock upon exercise of warrants (in Shares)
Sock based compensation - 2022 Equity Incentive Plan					172,853			$ 172,853
Net loss for the period							(2,281,742)	(2,281,742)
Balance at Jun. 30, 2024		$ 27	$ 796		$ 11,040,583		$ (7,304,949)	$ 3,736,457
Balance (in Shares) at Jun. 30, 2024		270,000	7,960,919

Statements of Stockholders_ E_2

Statements of Stockholders’ Equity (Deficit) (Parentheticals) - USD ($)		12 Months Ended
	Apr. 30, 2024	Jun. 30, 2024
Statement of Stockholders' Equity [Abstract]
Issuance of class B common stock pursuant to initial public offering, net of issuance and deferred offering costs	$ 1,656,453	$ 1,656,453

Statement of Cash Flows

Statement of Cash Flows - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities
Net loss	$ (320,064)	$ (5,023,207)	$ (2,281,742)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,420	109,144	155,059
Accretion of note payable discount			5,250
Non cash interest expense			85,593
Stock based compensation			670,958
Non cash lease expense			5,308
Imputed interest
Provision for bad debt and write-off of on uncollectable accounts			37,498
Changes in operating assets and liabilities:
Accounts receivable			(271,224)
Inventory			(211)
Due from related parties, net
Prepaid expenses			80,301
Deferred revenue			10,395
Accounts payable and accrued liabilities			(45,065)
Net cash used in operating activities			(1,547,880)
Investing activities
Purchase of property and equipment			(10,438)
Cash used in acquisition
Net cash used in investing activities			(10,438)
Financing activities
Proceeds from issuance of series seed preferred stock
Proceeds from issuance of class A common stock
Proceeds from issuance of class B common stock
Proceeds from issuance of class B common stock pursuant to Initial Public Offering, net of issuance costs			4,233,875
Proceeds from issuance of convertible notes			225,000
Payments from issuance of loans from related parties
Payments for deferred offering costs			(587,573)
Repayments of long term debt
Payment on note payable			(480,667)
Repayments of loans due to related parties			(208,900)
Net cash provided by (used in) financing activities			3,181,735
Net increase (decrease) in cash			1,623,417
Cash and cash equivalents at beginning of year			393,194
Cash and cash equivalents at the end of year		393,194	2,016,611	$ 393,194
Supplementary cash flow disclosure
Interest paid			436,346
Unpaid deferred offering costs
Shares issued for conversion from convertible note payable			257,480
Successor
Cash flows from operating activities
Net loss		(5,023,207)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		109,144
Accretion of note payable discount		12,750
Non cash interest expense		152,684
Stock based compensation		4,119,321
Non cash lease expense		19,864
Imputed interest
Provision for bad debt and write-off of on uncollectable accounts		8,641
Changes in operating assets and liabilities:
Accounts receivable		(107,942)
Inventory		475,009
Due from related parties, net
Prepaid expenses		(139,563)
Deferred revenue
Accounts payable and accrued liabilities		136,429
Net cash used in operating activities		(236,870)
Investing activities
Purchase of property and equipment		(1,260)
Cash used in acquisition		(2,000,000)
Net cash used in investing activities		(2,001,260)
Financing activities
Proceeds from issuance of series seed preferred stock		1,000,000
Proceeds from issuance of class A common stock		100
Proceeds from issuance of class B common stock		1,650,000
Proceeds from issuance of class B common stock pursuant to Initial Public Offering, net of issuance costs
Proceeds from issuance of convertible notes
Payments from issuance of loans from related parties		208,900
Payments for deferred offering costs		(227,676)
Repayments of long term debt
Payment on note payable
Repayments of loans due to related parties
Net cash provided by (used in) financing activities		2,631,324
Net increase (decrease) in cash		393,194
Cash and cash equivalents at beginning of year			$ 393,194
Cash and cash equivalents at the end of year		393,194		393,194
Supplementary cash flow disclosure
Interest paid		14,438
Unpaid deferred offering costs		75,079
Shares issued for conversion from convertible note payable
Predecessor
Cash flows from operating activities
Net loss	(320,064)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,420
Accretion of note payable discount
Non cash interest expense
Stock based compensation
Non cash lease expense
Imputed interest	125,728
Provision for bad debt and write-off of on uncollectable accounts	9,772
Changes in operating assets and liabilities:
Accounts receivable	101,423
Inventory	(157,596)
Due from related parties, net	4,686
Prepaid expenses	4,747
Deferred revenue	63,701
Accounts payable and accrued liabilities	43,932
Net cash used in operating activities	(117,251)
Investing activities
Purchase of property and equipment
Cash used in acquisition	(7,882)
Net cash used in investing activities	(7,882)
Financing activities
Proceeds from issuance of series seed preferred stock
Proceeds from issuance of class A common stock
Proceeds from issuance of class B common stock
Proceeds from issuance of class B common stock pursuant to Initial Public Offering, net of issuance costs
Proceeds from issuance of convertible notes
Payments from issuance of loans from related parties	164,917
Payments for deferred offering costs
Repayments of long term debt	(1,278)
Payment on note payable
Repayments of loans due to related parties	(288,861)
Net cash provided by (used in) financing activities	(125,222)
Net increase (decrease) in cash	(250,355)
Cash and cash equivalents at beginning of year	263,506	$ 13,151		$ 263,506
Cash and cash equivalents at the end of year	13,151
Supplementary cash flow disclosure
Interest paid	10
Unpaid deferred offering costs
Shares issued for conversion from convertible note payable

Organization and Business

Organization and Business	12 Months Ended
	Jun. 30, 2024
Organization and Business [Abstract]
Organization and Business	1. Organization and Business CC Acquisition Corp. was incorporated in the State of Nevada on August 23, 2022 for the sole purpose of acquiring substantially all of the assets of CleanCore Solutions, LLC, TetraClean Systems, LLC, and Food Safety Technologies, LLC, pursuant to an asset purchase agreement entered into by CC Acquisition Corp. with these three entities and their owners on October 17, 2022. On November 21, 2022, CC Acquisition Corp. changed its name to CleanCore Solutions, Inc. (the Company” or “Successor”). Since the Company acquired substantially all of the assets of each of CleanCore Solutions, LLC, TetraClean Systems, LLC, and Food Safety Technologies, LLC, the business of these three entities is now operated by the Company, with no subsidiaries. The combined results of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC presented in these financial statements represent the predecessor entity of the Company (the “Predecessor”). The Company specializes in the development and production of cleaning products that produce pure aqueous ozone products for professional, industrial, or home use. The Company has a patented nanobubble technology using aqueous ozone that it believes is highly effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The Company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores. The headquarters, principal address and records of the Company are located at 5920 South 118th Circle, Suite 2, Omaha, Nebraska. Initial Public Offering On April 30, 2024, the Company closed its initial public offering of 1,250,000 shares of common stock at a price to the public of $4.00 per share for gross offering proceeds of $ 5,000,0000 Liquidity The Company has incurred losses and negative cash flows from operations. From acquisition through June 30, 2024, the Company has financed its operations primarily through investor funding. As of June 30, 2024, the Company had cash of $2,016,611, a net loss of $2,281,742, and cash used in operating activities of $1,547,880. In accordance with Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern, management is required to perform a two-step analysis over the Company’s ability to continue as a going concern. Management must first evaluate whether there are conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the date the financial statements are issued. If management concludes that substantial doubt is raised, management is also required to consider whether its plans alleviate that doubt. Despite the initial public offering described above, management believes that currently available resources will not be sufficient to fund the Company’s planned expenditures over the next 12 months. These factors, individually and collectively indicate that a material uncertainty exists that raises substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date of issuance of these financial statements. The Company will be dependent upon the raising of additional capital through equity and/or debt financing in order to implement its business plan and generate sufficient revenue in excess of costs. If the Company raises additional capital through the issuance of equity securities or securities convertible into equity, stockholders will experience dilution, and such securities may have rights, preferences or privileges senior to those of the holders of common stock. If the Company raises additional funds by issuing debt, the Company may be subject to limitations on its operations, through debt covenants or other restrictions. There is no assurance that the Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on the Company’s financial condition. These financial statements do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The financial statements of the Company (Successor) are presented since the date of acquisition (October 17, 2022) through the period ended June 30, 2023. The results of the Predecessor represent the combined financial statements of the accounts of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC. These combined financial statements include the accompanying combined statements of operation, combined statement of members’ equity and combined statement of cash flows for the period July 1, 2022 through October 16, 2022. All intercompany balances and transactions among the combined entities have been eliminated. In the opinion of predecessor management, all adjustments considered necessary for a fair presentation have been included. Use of Estimates The preparation of the Company’s and Predecessor’s financial statements require management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure in the Company’s combined financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates. Significant estimates and assumptions made by the Company are allowance for bad debt, useful lives of fixed assets, warranty liabilities, accrued contingent liabilities, and allowance for inventory obsolescence. Risks and Uncertainties The Company is subject to a number of risks similar to other early-stage companies including, but not limited to, profitability, the need for additional financing to achieve its business strategy, ability to obtain regulatory approval, significant competition, and dependence on key individuals. Cash and Cash Equivalents Cash consists of cash in readily available checking and money market accounts. Cash is recorded at cost, which approximates fair value. As of June 30, 2024 and 2023, cash balances were deposited at a major financial institution. Cash balances are subject to minimal credit risk as the balances are with high credit quality financial institutions. Concentration of Credit Risk Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist of cash. The Company maintains deposits in federally insured financial institutions in excess of respective insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. Major Customers The Company had one customer that accounted for of 14% of its revenues for the year ended June 30, 2024 and two customers that accounted for a total 66% of revenue for the year ended June 30, 2023. Collateral is not required for customer accounts receivable balances. The Company maintains an allowance for doubtful accounts as described in “Accounts Receivable” below. The Company had two customers that accounted for 28% each of total accounts receivable at June 30, 2024, and two customers that accounted for 43% and 12%, respectively, of total accounts receivable at June 30, 2023. Major Vendors The Company has one vendor each that it exclusively purchases a major component of its two main products. The Company expects to maintain this relationship with the vendor; however, it does have a contingency plan in place to use other vendors if necessary, which would result in minor production delays. Accounts Receivable Accounts receivable is comprised of trade accounts receivables from the Company’s customers. Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company established an allowance for bad debt of accounts receivables based on a percentage assigned to aged days outstanding categories. The Predecessor established the allowance for bad debt based on various factors including credit profiles of the Company’s customers, historical payments, outstanding balances and current economic trends, and performed this analysis periodically. The Company recorded an allowance for doubtful accounts of $2,535 and $4,419 as of June 30, 2024 and 2023, respectively. Inventory Inventory consists of parts, work in progress and finished goods. The Company values parts and finished goods at the lower of the actual costs or net realizable value. The Company values work in progress at cost. The Company periodically reviews inventory for obsolete and potentially impaired items. As of June 30, 2024 and 2023, the Company had an allowance for inventory obsolescence of $14,791 and $14,940, respectively. Leases The Company accounts for leases in accordance with ASC Topic 842 (Topic 842), Leases Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, and probable amounts the lessee will owe under a residual value guarantee. Variable lease payments are recognized as lease expenses as incurred, and generally relate to variable payments made based on the level of services provided by the landlords of our leases. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term within general and administrative expenses in the statement of operations. The Company uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments because the Company does not have the information necessary to determine the rate implicit in the lease. The Company’s lease term includes any option to extend the lease when it is reasonably certain to be exercised based on consideration of all relevant factors. Leases with an initial term of 12 months or less are not recorded on the balance sheets and the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Business Combinations Business combinations are accounted for using the acquisition method. The fair value of total purchase consideration is allocated to the fair values of identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount being classified as goodwill. All assets, liabilities and contingent liabilities acquired or assumed in a business combination are recorded at their fair values at the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Estimates of fair value are based on assumptions believed to be reasonable, but are inherently uncertain and unpredictable and, as a result, actual results may differ from those estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in the statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s statements of operations. Intangible Assets Intangible assets primarily consist of existing technology, customer relationships, and trademarks obtained as a result of the acquisition on October 17, 2022. Intangible assets with definite lives are amortized based on their pattern of economic benefit over their estimated useful lives and reviewed periodically for impairment. The Company’s trademarks are deemed to have an indefinite life. The estimated useful life of the acquired technology is 15 years while the estimated useful life of the customer relationships is 5 years. Impairment of Goodwill The Company evaluates goodwill for impairment annually, as of June 30, or more frequently when indicators of impairment exist. The Company considers qualitative factors including market conditions, legal factors, operating performance indicators, and competition, among others, to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount, including goodwill. If the Company concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company performs a quantitative impairment test. In performing the quantitative impairment test, the Company compares the fair value of its reporting unit to the carrying amount including the goodwill of the reporting unit. If the carrying value, including goodwill, exceeds the reporting unit’s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company performed its annual evaluation of goodwill on June 30, 2024. Based on the analysis, the Company did not recognize an impairment loss during the year ended June 30, 2024. Subsequent evaluations will be performed annually on June 30, per the Company’s policy. Impairment of Long-Lived Assets Long-lived assets consist primarily of property and equipment and intangible assets. Long-lived assets are tested for impairment when events and circumstances indicate the assets might be impaired by first comparing the estimated future undiscounted cash flows of the asset or asset group to the carrying value. If the carrying value exceeds the estimated future undiscounted cash flows, an impairment loss is recognized based on the amount that the carrying value exceeds the fair value of the asset or asset group. The Company did not recognize impairment losses during the periods ended June 30, 2024 and 2023. Deferred Offering Costs In accordance with ASC 340-10-S99-1 and SEC Accounting Bulletin Topic 5A, specific incremental costs incurred by the Company directly attributable to a proposed offering of securities were deferred. As the initial public offering closed on April 30, 2024, a total of $890,453 deferred costs were charged against the gross proceeds of the offering for the year ended June 30, 2024. These offering costs included fees paid to underwriters, attorney, accountants as well as printers and other third parties directly related to the offering. Costs such as management salaries or other general administrative expenses that are not incremental to the offering are not included in the deferred costs. Patent Costs Costs related to filing and pursuing patent applications are expensed as incurred, as recoverability of such expenditures is uncertain. These costs are included in general and administrative expenses. Advertising Costs The Company reports as expense the cost of advertising and promoting its services as incurred. Such amounts totaled $116,007 for the year ended June 30, 2024, and $4,621 and $14,944 for the period and year ended October 16, 2022 and June 30, 2023, respectively. Stock-based Compensation Compensation expense is recognized for all share-based payments to employees and nonemployees, including stock options, restricted stock awards, and warrants, in the statements of operation based on the fair value of the awards that are granted. As necessary, the Company’s stock price at the date of grant was estimated using an acceptable valuation technique such as the probability-weighted expected return model. The fair value of stock options and warrants are estimated at the date of grant using the Black-Scholes option-pricing model. The fair value of restricted stock awards is based on the fair market value of the Company’s class B common stock on the date of grant. Compensation expense for restricted stock awards with performance-based vesting conditions is calculated based on the number of awards that are expected to vest during the performance period if it is probable that the performance metrics will be achieved. Generally, measured compensation cost, net of actual forfeitures, is recognized on a straight-line basis over the vesting period of the related share-based compensation award. The Company accounts for forfeitures of stock-based awards as they occur. Revenue Recognition The Company generates revenues from sales of its products and recognizes revenue as control of its products is transferred to its customers, which is generally at the time of shipment based on the contractual terms with the Company’s customers. The Company provides customer programs and incentive offerings, including growth incentives and volume-based incentives. These customer programs and incentives are considered variable consideration. The Company includes in revenue variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the variable consideration is resolved. This determination is made based upon known customer program and incentive offerings at the time of sale and expected sales volume forecasts as it relates to the Company’s volume-based incentives. This determination is updated every reporting period. For the years ended June 30, 2024 and 2023, customer growth and volume-based incentives were minimal. Certain product sales include a 2-year manufacturer’s warranty that provides the customer with assurance that the product performs as intended. Such warranties are assurance-type warranties and are accounted for as contingencies under ASC 460-10. Refer to Note 10 for warranty reserve. Income Taxes The Company accounts for income tax on the basis of the tax laws enacted at the balance sheet date in accordance with FASB ASC 740, Income Taxes Tax positions are recognized if it is more-likely-than-not, based on technical merits, that the tax position will be realized or sustained upon examination. The term “more-likely-than-not” means a likelihood of more than 50%; the terms examined and upon examination also include resolution of the related appeals or litigation processes, if any. A tax position that meets the more-likely-than-not recognition threshold is initially and subsequently measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. The determination of whether or not a tax position has met the more-likely-than-not recognition threshold considers the facts, circumstances and information available at the reporting date and is subject to management’s judgment. Net Loss per Share of Common Stock Basic net loss per class A and class B common share is calculated by dividing the net loss distributed to class A and class B, respectively, by the weighted-average number of common shares of each respective class outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants are considered to be potentially dilutive securities. As of June 30, 2024 and 2023, there were 3,382,500 and 2,816,263, respectively, of potential common stock equivalents excluded from the diluted loss per share calculations as their effect is anti-dilutive. Because the Company has reported a net loss for the years ended June 30, 2024 and 2023, diluted net loss per common share is the same as basic net loss per common share for such years. New Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires greater disaggregation of income tax disclosures related to the income tax rate reconciliation and income taxes paid and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued. The amendments should be applied on a prospective basis although retrospective application is permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance in this update is effective for all public entities for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures.

Disaggregated Revenue

Disaggregated Revenue	12 Months Ended
	Jun. 30, 2024
Disaggregated Revenue [Abstract]
Disaggregated Revenue	3. Disaggregated Revenue The following table disaggregates revenue by product category for the following periods ended: Year Ended October 17, July 1, Janitorial & Sanitation $ 1,518,079 $ 1,732,611 $ 369,089 Ice System 19,495 30,195 16,744 Commercial and Residential Laundry 21,129 5,016 6,444 Sanitizing & Disinfecting Tablets - 3,140 160 Other 46,270 167,404 110,553 Total revenue $ 1,604,973 $ 1,938,366 $ 502,990 The “Other” category of revenue consists primarily of sales of parts, accessories, shipping and handling, and equipment rental income.

Accounts Receivable, Net

Accounts Receivable, Net	12 Months Ended
	Jun. 30, 2024
Accounts Receivable, Net [Abstract]
Accounts Receivable, net	4. Accounts Receivable, net Accounts receivable, net consists of the following at: June 30, June 30, Trade accounts receivable $ 469,821 $ 237,979 Allowance for doubtful accounts (2,535 ) (4,419 ) Total accounts receivable, net $ 467,286 $ 233,560

Business Combinations

Business Combinations	12 Months Ended
	Jun. 30, 2024
Business Combinations [Abstract]
Business Combinations	5. Business Combinations On October 17, 2022, the Company acquired substantially all of the assets of the Predecessor and accounted for this transaction as a business combination under ASC 805 as it falls under the definition. The purpose of the transaction was to acquire and further develop and manufacture patented cleaning products. Total consideration for the acquisition consisted of a $2,000,000 payment made at closing and a $3,000,000 note payable, bearing interest at 7% per annum, to the seller. In addition, if the Company reaches certain metrics as defined in the purchase agreement, in the 12-month period following the closing date, the Company shall make a one-time payment of $500,000 as an adjustment to the purchase price. However, due to forecasted net income being negative, the contingent consideration was valued at $0. The following table summarizes the fair value of the consideration paid and the fair value of assets acquired and liabilities assumed on October 17, 2022, the acquisition date. Consideration Total payments at closing $ 2,000,000 Note payable to seller at fair value 2,982,000 Contingent consideration at fair value - Fair value of total consideration $ 4,982,000 Recognized amounts of identifiable assets acquired and liabilities assumed Accounts receivable $ 134,259 Inventory 1,204,023 Prepaids assets 5,543 Existing technology 600,000 Customer relationships 570,000 Tradenames/trademarks 580,000 Accounts payable and current liabilities (349,735 ) Total identifiable net assets $ 2,744,090 Goodwill 2,237,910 $ 4,982,000 The acquired technology consisted of patented nanobubble technology that produces an aqueous ozone solution that requires no additives, filters, or advanced chemicals. The pure aqueous ozone product is a natural cleaner, sanitizer, and deodorizer produced through the infusion of ozone into water using electricity. The technology was valued using the multi-period excess earnings method. Under this method, the fair value of the asset reflects the present value of the projected stream of net cash flows that will be generated by the asset over the projection period. Key inputs and assumptions in determining the fair value include projected cash flows and the discount rate used to calculate the present value of such cash flows. The developed technology will be amortized over a useful life of 15 years. Customer relationships relate to contracts with distributors that were acquired while the trademarks refer to the predecessor’s trademarks that continue to be used. The trademarks are deemed to have an indefinite life. The goodwill of $2,237,910 arising from the acquisition consists largely of the synergies, cost savings, and economies of scale expected from combining the operations of the acquired assets and the Company and further developing its products. The goodwill is deductible over 15 years for tax purposes. The Company incurred $31,676 of acquisition-related costs which have been recorded within general and administrative expenses in the statement of operations for the period ended June 30, 2023.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jun. 30, 2024
Fair Value Measurements [Abstract]
Fair Value Measurements	6. Fair Value Measurements ASC Topic 820, Fair Value Measurement ASC 820 identifies fair value as the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes between the following: Level 1 – Observable inputs such as quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than quoted prices in active markets, that are observable for the asset or liability, either directly or indirectly. Level 3 – Unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. The Company’s financial assets are subject to fair value measurements on a recurring basis. The Company’s remaining carrying amounts reported in the combined balance sheets of these financial assets are a reasonable estimate of fair value due to their short-term nature.

Inventory

Inventory	12 Months Ended
	Jun. 30, 2024
Inventory [Abstract]
Inventory	7. Inventory Inventory consists of the following at: June 30, June 30, Parts $ 503,004 $ 551,264 Finished goods 184,112 135,792 Inventory reserve (14,790 ) (14,940 ) Total inventory, net $ 672,326 $ 672,116 The Company values inventory at the balance sheet date using the weighted average method. The Company recorded an inventory reserve of $14,790 and $14,940 for the years ended June 30, 2024 and 2023, respectively.

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Jun. 30, 2024
Property and Equipment, Net [Abstract]
Property and Equipment, Net	8. Property and Equipment, Net Property and equipment, net, consist of the following at: June 30, June 30, Equipment $ 8,217 $ - Vehicles - - Furniture and fixtures - - Leasehold improvements 3,481 1,260 Total 11,698 1,260 Less: accumulated depreciation (1,126 ) (63 ) Total property and equipment, net $ 10,572 $ 1,197 Depreciation expense related to property and equipment was $1,063 and $63 for the years ended June 30, 2024 and 2023, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
Intangible Assets	9. Intangible Assets Intangible assets consist of the following at: June 30, June 30, Technology $ 600,000 $ 600,000 Customer relationships 570,000 570,000 Trademarks 580,000 580,000 Total 1,750,000 1,750,000 Less: accumulated amortization (263,077 ) (109,081 ) Total intangible assets, net $ 1,486,923 $ 1,640,919 The Company holds 14 patents, which are included in technology. These patents cover the functions of the Company’s products that allow its machines to produce the ozone in the form of nanobubbles. Amortization expense related to intangibles was $153,996 and $109,081 for the years ended June 30, 2024 and 2023, respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Jun. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]
Accounts Payable and Accrued Expenses	10. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consist of the following at: June 30, June 30, Accounts payable $ 176,077 $ 266,511 Accrued interest 23,113 152,684 Accrued payroll and related expenses 59,943 68,026 Accrued pending litigation (Note 17) 108,242 - Warranty reserve 96,636 156,333 Accrued severance 70,000 - Other accrued expenses 39,945 1,073 Total accounts payable and other accrued expenses $ 573,956 $ 644,627

Debt

Debt	12 Months Ended
	Jun. 30, 2024
Debt [Abstract]
Debt	11. Debt Burlington Promissory Note In connection with the acquisition of the Predecessor on October 17, 2022, the Company issued a promissory note in the principal amount of $3,000,000 to the seller, Burlington Capital, LLC (“Burlington”), which bore interest at 7% per annum and was to mature on October 17, 2023. On September 13, 2023, the parties signed an extension agreement, pursuant to which the interest rate was increased to 10% per annum and the maturity date was extended to the earlier of (a) the closing of a firm commitment initial public offering and concurrent listing on a national securities exchange or (b) December 17, 2023. On December 17, 2023, the parties signed a second extension agreement, pursuant to which the maturity date was extended to the earlier of (a) the closing of a firm commitment initial public offering and concurrent listing on a national securities exchange or (b) April 4, 2024. On April 30, 2024, the Company and Burlington entered into an extension agreement which extended the maturity date to May 9, 2024. On May 31, 2024, Burlington and Walker Water LLC (“WW”) entered into an allonge, assignment and agreement (the “Assignment Agreement”), pursuant to which Burlington agreed to transfer $633,840 of the note to WW. The Assignment Agreement also provided that the Company make a payment of $900,000 on May 31, 2024 to Burlington to reduce the principal amount of the note by $480,667 and pay the outstanding accrued interest of $419,333 in full. Also on May 31, 2024, the Company issued an amended and restated promissory note to Burlington (the “Amended Note”). The Amended Note has a new principal amount of $2,366,160, accrues interest at 8.5% per annum from October 17, 2022 (the date of the original note), which shall increase to 10% upon an event of default, and requires quarterly payments in the amount of $100,000 over the course of the next two and a half years, with a final payment of $1,396,881 due on April 1, 2027. The Amended Note may be prepaid at any time with no pre-payment penalty and contains customary events of default for a note of this type. As of June 30, 2024, the outstanding principal balance of this note is $1,885,493 and it has accrued interest of $13,673. Pursuant to the Assignment Agreement, the Company also issued a promissory note to WW in the principal amount of $633,840 (the “New Note”). The New Note accrues interest at 8.5% per annum from October 17, 2022 (the date of the original note), which shall increase to 10% upon an event of default and is due on December 31, 2024. The New Note may be prepaid at any time with no pre-payment penalty and contains customary events of default for a note of this type. As of June 30, 2024, the outstanding principal balance of this note is $633,840 and it has accrued interest of $4,490. Convertible Promissory Notes On January 30, 2024, the Company issued three 10% original issue discount convertible promissory notes to three separate accredited investors in the principal amounts of $27,778, $111,111, and $111,111. The purchase prices of the notes were $25,000, $100,000 and $100,000, respectively. These notes accrued simple interest on the outstanding principal amount at the rate of 12% per annum. On May 2, 2024, the Company issued an aggregate of 257,479 shares of class B common stock upon the conversion of these notes, which included principal of $225,000 and accrued interest of $37,479. Line of Credit On June 28, 2024, the Company entered into a loan agreement with Arbor Bank for a revolving line of credit in the amount of $100,000 with a variable interest rate tied to the U.S. Prime Rate. Monthly payments of accrued interest are due beginning July 28, 2024. The principal and any outstanding accrued interest are due in full on June 28, 2025. No interest was required to be accrued as of June 30, 2024.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	12. Related Party Transactions The following due to related party balances were outstanding at: June 30, June 30, Due to founder – credit card $ 91,119 $ 12,402 Due to founders - 208,900 Total due to related parties $ 91,119 $ 221,302 At June 30, 2024, the Company had a short term amount due to Clayton Adams, its Chief Executive Officer and founder, in the amount of $91,119 for operational expenses paid by a credit card in his name. At June 30, 2023, that amount was $12,402. The Company has a verbal agreement with Mr. Adams to pay the credit card charges directly to the issuing financial institution as they become due and is current on these payments. On October 4, 2022, the Company issued a promissory note to each of Matthew Atkinson, the Company’s Chief Executive Officer at such time, and Clayton Adams, the Company’s President at such time, in the principal amount of $104,450 each for a total of $208,900. These notes bore interest at a rate of 5% per annum beginning on the 30th day after issuance and were due on the 60th day following written demand from the holder. As of June 30, 2023, the Company recorded this as a short-term note payable on the balance sheet, due to the demand terms of the agreement, and recorded related accrued interest of $7,698. On May 29, 2024, the Company repaid these two promissory notes, including interest accrued of $8,506 each. On October 17, 2022, the Company entered into a consulting agreement with Birddog Capital, LLC (“Birddog”), a limited liability company owned by Clayton Adams, a significant security holder at such time and the Company’s current Chief Executive Officer, pursuant to which the Company engaged Birddog to provide management services to the Company. Pursuant to the consulting agreement, the Company agreed to pay Birddog a monthly fee of $6,000 commencing on October 17, 2022. The Company also agreed to reimburse Birddog for all pre-approved business expenses. The term of the consulting agreement was for one (1) year. On April 1, 2024, the Company entered into a new consulting agreement with Birddog which provides for a monthly fee of $22,000. In addition, the Company agreed to pay Birddog $175,000 upon completion of the initial public offering and grant Birddog 500,000 restricted stock units, with 250,000 shares vesting immediately and 250,000 shares vesting eighteen months after issuance. The consulting agreement expires on October 23, 2025. On October 17, 2022, the Company entered into a consulting agreement with Elev8, a business consulting company owned by Matthew Atkinson, the Company’s President and a significant security holder at such time, pursuant to which the Company engaged Elev8 to provide management services to the Company. Pursuant to the consulting agreement, the Company agreed to pay Elev8 a monthly fee of $6,000 commencing on October 17, 2022. The Company also agreed to reimburse Elev8 for all pre-approved business expenses. The Company has no outstanding balances related to this agreement as of June 30, 2024. On July 27, 2023, the Company agreed to purchase approximately $105,000 worth of inventory from Nebraska C. Ozone, LLC, a related party business owned by Lisa Roskens, a significant stockholder and the principal officer of Burlington, due to an open purchase order that the Predecessor had with an inventory vendor that was not included in the liabilities assumed from the Predecessor per the terms of the acquisition purchase agreement. The inventory is to be purchased as needed, consistent with other inventory purchases. However, if the entire $105,000 amount is not purchased by March 31, 2024, the balance at that date begins accruing interest at a rate of seven percent (7%) per annum until it is paid in full. As of June 30, 2024, the Company has not purchased any of the inventory and as such, has accrued interest of $2,471. On March 26, 2024, the Company entered into a loan agreement with Clayton Adams, a significant stockholder, pursuant to which the Company issued a revolving credit note to Mr. Adams in the principal amount of up to $500,000. Pursuant to the loan agreement and note, Mr. Adams agreed to provide advances to the Company upon request during the period commencing on April 25, 2024 and continuing until the second anniversary of such date, which is referred to as the maturity date. This note accrues simple interest on the outstanding principal amount at the rate of 8% per annum, with all principal and interest due on the maturity date; provided that upon an event of default (as defined in the note), such rate shall increase to 13%. The Company may prepay the note at any time without penalty or premium. The note is unsecured and contains customary events of default for a loan of this type. As of June 30, 2024, no advances have been made and the principal amount of this note is $0.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Jun. 30, 2024
Stockholders’ Equity [Abstract]
Stockholders' Equity	13. Stockholders’ Equity The Company’s authorized capital stock as of June 30, 2024 consists of 350,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, of which 50,000,000 shares are designated class A common stock and 250,000,000 shares are designated as class B common stock; and (ii) 50,000,000 shares of “blank check” preferred stock, par value $0.0001 per share, of which 4,000,000 are designated as series seed preferred stock. Series Seed Preferred Stock Below is a summary of the terms of the series seed preferred stock. Ranking Liquidation Rights Dividends Voting Rights Conversion Rights For the Year Ended June 30, 2023 In September 2022, the Company issued an aggregate of 4,000,000 shares of series seed preferred stock at a purchase price of $0.25 per share. As of June 30, 2023, 4,000,000 shares of series seed preferred stock were issued and outstanding. For the Year Ended June 30, 2024 During the year ended June 30, 2024, a total of 4,000,000 shares of series seed preferred stock were converted into 4,000,000 shares of class A common stock. As of June 30, 2024, no shares of series seed preferred stock were issued and outstanding. Common Stock The Company has two classes of authorized common stock — class A common stock and class B common stock. The rights of the holders of the class A common stock and class B common stock are identical, except with respect to voting and conversion. Each share of class A common stock is entitled to ten votes per share and is convertible into one share of class B common stock. Each share of class B common stock is entitled to one vote per share. As of June 30, 2024, all of the outstanding class A common stock was held by one of the Company’s founders, which is also the current Chief Executive Officer. For the Year Ended June 30, 2023 On August 26, 2022, the Company issued an aggregate of 1,000,000 shares of class A common stock at a purchase price of $0.0001 per share. In October and November 2022, the Company issued an aggregate of 660,921 shares of class B common stock at a purchase price of $1.74 per share. On November 29, 2022, the Company issued 777,778 shares of class B common stock upon the exercise of a warrant for an aggregate exercise price of $500,000. On April 1, 2023, the Company issued 17,241 shares of class B common stock to a professional firm in exchange for services at $1.74 per share. Accordingly, stock compensation expense in the amount of $29,999 was recorded by the Company. On June 1, 2023, an aggregate of 340,000 shares of class A common stock were converted into an aggregate of 340,000 shares of class B common stock. As of June 30, 2023, there were 660,000 shares of class A common stock and 1,795,940 shares of class B common stock issued and outstanding. For the Year Ended June 30, 2024 In July 2023, the Company issued 1,000,000 shares of class A common stock upon the conversion of 1,000,000 shares of series seed preferred stock. In addition, the Company issued a total of 1,310,000 shares of class B common stock upon the conversion of 1,310,000 shares of class A common stock. In February 2024, the Company issued a total of 2,000,000 shares of class A common stock upon the conversion of 2,000,000 shares of series seed preferred stock, which were immediately converted into 2,000,000 shares of class B common stock upon issuance. On February 6, 2024, the Company issued 200,000 shares of class B common stock upon the conversion of 200,000 shares of class A common stock. On April 30, 2024, the Company issued 1,000,000 shares of class A common stock upon the conversion of 1,000,000 shares of series seed preferred stock. In addition, upon closing of the initial public offering, the Company sold 1,250,000 shares of class B common stock for proceeds of $3,343,547, net of $1,656,453 of issuance and deferred offering costs. On April 30, 2024, the Company issued 175,000 shares of class B common stock pursuant to restricted stock award and 87,500 shares of class B common stock upon vesting of a restricted stock unit award granted under the 2022 Plan (as defined below). On May 2, 2024, the Company issued an aggregate of 257,479 shares of class B common stock upon the conversion of the 10% original issue discount convertible promissory notes issued on January 30, 2024 (see Note 11), which included principal of $225,000 and accrued interest of $37,479. On May 15, 2024, the Company issued 880,000 shares of class B common stock upon the conversion of 880,000 shares of class A common stock. On June 12, 2024, the Company issued 5,000 shares of class B common stock upon vesting of a restricted stock unit award granted under the 2022 Plan. As of June 30, 2024, there were 270,000 shares of class A common stock and 7,960,919 shares of class B common stock issued and outstanding. 2022 Equity Incentive Plan On September 16, 2022, the Company’s board of directors adopted the Company’s 2022 Equity Incentive Plan (as amended, the “2022 Plan”), which was adopted by stockholders on November 18, 2022, which reserved a total of 1,736,819 share of the Company’s class B common stock for issuance. On January 3, 2024, the Company adopted an amendment to the 2022 Plan, which increased the total shares of class B common stock available for grant to 3,240,000. Additionally, the number of shares of class B common stock available for issuance under the 2022 Plan will automatically increase on January 1 of each calendar year during the term of the 2022 Plan by an amount equal to 5% of the total number of shares of class B common stock issued and outstanding on December 31 of the immediately preceding calendar year. Incentive awards authorized under the 2022 Plan include, but are not limited to, nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance grants intended to comply with Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and stock appreciation rights. If an incentive award granted under the 2022 Plan expires, terminates, is unexercised or forfeited, the surrendered shares will become available for future awards under the 2022 Plan. The Company’s employees and advisors were granted awards under the 2022 Plan. Therefore, an allocation of the share-based compensation was made to the Company. Stock Options During the year ended June 30, 2023, the Company had issued options to purchase an aggregate of 2,000,000 shares of class A common stock at an exercise price of $0.25 per share outside of the 2022 Plan and 770,000 shares of class B common stock at an average price of $2.21 per share under the 2022 Plan. During the year ended June 30, 2024, the Company issued additional options to purchase 525,000 shares of class B common stock at a weighted average exercise price of $3.31 per share under the 2022 Plan. All of the class A options and 75,000 of the class B options were fully vested as of the grant date. The remaining class B options have a graded vesting term based on continuous service during the vesting period. Warrants On October 14, 2022 and November 29, 2022, the Company issued warrants for the purchase of 42,241 and 4,022 shares of class B common stock, respectively, to a third party as part of their compensation earned. The warrants are exercisable for a period of five years at an exercise price of $1.74 (subject to adjustments for stock dividends, stock splits, mergers, consolidations and similar transactions). On March 5, 2024, the Company cancelled these warrants without issuing a replacement award. As the warrants were already vested, previously recognized compensation cost was not reversed. On October 17, 2022, the Company issued a warrant for the purchase of 777,778 shares of class B common stock for an aggregate exercise price of $500,000 to Burlington. On November 29, 2022, Burlington exercised this warrant in full. On April 30, 2024, the Company issued a warrant for the purchase of 87,500 shares of class B common stock at an exercise price of $5.00, subject to adjustments, to the representative of the underwriters in the initial public offering. The warrant will be exercisable at any time and from time to time, in whole or in part, during the period commencing on April 30, 2024 and ending on April 25, 2029 and may be exercised on a cashless basis under certain circumstances. Restricted Stock Awards On April 30, 2024, the Company granted a restricted stock award under the 2022 Plan for 175,000 shares of class B common stock, of which 15,000 shares vested on the date of grant, 10,625 shares will vest quarterly through June 30, 2026 and the remaining 75,000 shares will vest as the grantee reaches certain sales targets in a twelve month period. On April 30, 2024, the Company granted a restricted stock unit award under the 2022 Plan for 1,300,000 shares of class B common stock, of which 87,500 shares vested and were issued on the date of grant. In June 2024, the participant and the Company agreed to separate. As a result, the participant kept the 87,500 shares that were vested and forfeited all other shares available under the award. In addition to the 87,500 shares, the participant will also receive 20,000 shares of class B common stock on January 2, 2025. On June 12, 2024, the Company granted a restricted stock unit award under the 2022 Plan for 188,000 shares of class B common stock, of which 5,000 shares vested and were issued on the date of grant and, 5,000 will vest on July 12, 2024. In addition, 18,000 shares vest upon completion of tasks as outlined between the Company and grantee and an additional 160,000 shares will vest as the Company achieves certain sales targets in a twelve-month period. The information presented in the following table represents the restricted stock awards, including performance-based awards, granted and outstanding during the period: Performance- Service-Based Weighted Beginning balance - - $ - Granted - - - Forfeited - - - Vested - - - Outstanding, unvested grants at June 30, 2023 - - - Granted 235,000 - 3.10 Granted - 1,448,000 3.10 Forfeited - (1,212,500 ) 3.10 Vested - (107,500 ) 3.10 Outstanding, unvested grants at June 30, 2024 235,000 128,000 $ 3.09 Stock-based Compensation Stock options and warrants are granted at the fair market value of the underlying common stock on the date of grant. The Company recognizes compensation expense for these awards using the straight-line recognition method over the vesting period. The fair value of stock options and warrants was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted average assumptions for the years ended June 30, 2024 and 2023: June 30, June 30, Risk-free interest rate 5.10 % 3.80 % Dividend yield 0.0 % 0.0 % Expected volatility 47.44 % 54.04 % Expected life of awards 3.3 years 3.9 years Fair value of awards granted during the year $ 0.90 $ 1.35 The risk-free interest rate is based on U.S. government issues with a remaining term equal to the expected life of the awards. The determination of expected volatility is based on historical volatility of an appropriate industry sector index. The weighted average expected term was estimated for options using the average of the vesting term and contractual term of the awards. The weighted-average fair value per share of total awards granted during the years ended June 30, 2024 and 2023 was $1.35 and $0.90, respectively. Warrants Stock Weighted Weighted Beginning balance - - - $ - Granted 824,041 - 0.44 0.69 Granted - 2,770,000 4.77 0.51 Cancelled - - - - Forfeited - - - - Exercised (777,778 ) - - 0.61 Outstanding, June 30, 2023 (2,125,152 shares exercisable) 46,263 2,770,000 5.01 $ 0.59 Granted - 525,000 2.44 3.31 Granted 87,500 0.86 0.86 Cancelled (46,263 ) - 0.08 Forfeited - - - - Exercised - - - - Outstanding, June 30, 2024 (2,738,472 shares exercisable) 87,500 3,295,000 3.30 $ 4.17 Total stock compensation expense for the year ended June 30, 2024 was $670,958. In addition, $94,850 of warrants issued to representative of the underwriters in the initial public offering during the year ended June 30, 2024 were recorded as an offset to equity. Total stock compensation expense for the period ended June 30, 2023 consists of $3,231,443 related to stock options and $857,889 of warrants. In addition, $42,835 of warrants issued to representative of the underwriters in the initial public offering were recorded as an offset to equity as of June 30, 2024. As of June 30, 2024, total unrecognized stock compensation expense was $930,433 with the weighted average period over which it is expected to be recognized of 2.01 years.

Net Loss Per Share

Net Loss Per Share	12 Months Ended
	Jun. 30, 2024
Net Loss Per Share [Abstract]
Net Loss Per Share	14. Net Loss Per Share The following table sets forth the computation of basic and dilutive net income per share of class A and class B common stock: Year Ended June 30, 2024 Class A Class B Basic and diluted net loss per share: Numerator Allocation of undistributed loss $ (171,420 ) $ (2,110,322 ) Denominator Weighted average number of shares used in per share computation 350,192 4,311,142 Basic and diluted net loss per share $ (0.49 ) $ (0.49 ) Period Ended June 30, 2023 (Successor) Class A Class B Basic and diluted net loss per share: Numerator Allocation of undistributed loss $ (2,111,882 ) $ (2,911,325 ) Denominator Weighted average number of shares used in per share computation 967,987 1,334,414 Basic and diluted net loss per share $ (2.18 ) $ (2.18 )

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2024
Income Taxes [Abstract]
Income Taxes	15. Income Taxes The Company files income tax returns in the U.S. federal and applicable state jurisdictions. Management is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. The fiscal year ended June 30, 2023 was the entity’s initial year of existence, and is not subject to federal or state tax examinations prior to this period. The Company’s provision for income taxes is comprised of the following components for the year ended June 30, 2024: Years Ended 6/30/2024 6/30/2023 Current Tax Expense (Benefit) Federal - - State - - Current Tax Expense (Benefit) $ - $ - Deferred Tax Expense (Benefit) Federal - - State - - Deferred Tax Expense (Benefit) - - Total Income Tax Expense (Benefit) $ - $ - The Company’s income tax expense from continuing operations for the year ended June 30, 2024 differed from the statutory federal rate of 21% as follows: Pre-Tax Book Income $ (2,281,742 ) Years Ended 6/30/2024 6/30/2023 Amount Percent Amount Percent Rate Reconciliation Federal tax (benefit) at a statutory rate $ (479,166 ) 21 % $ (1,054,873 ) 21.00 % State tax expense (benefit) (125,968 ) 5.52 % (277,654 ) 5.53 % Other Permanent Differences 804 (0.04 )% 490 (0.01 )% Increase (Decrease) in valuation allowance related to current period P&L activity 604,330 (26.49 )% 1,332,037 (26.52 )% Total tax expense $ - 0.00 % $ - 0.00 % Deferred tax assets and liabilities consist of the following at June 30, 2024: Years Ended 6/30/2024 6/30/2023 Deferred Tax Assets Accrued Expenses $ 67,775 $ 55,680 Equity Compensation 1,186,561 1,092,856 Lease Liabilities 145,913 129,075 NOL Carryforwards 720,498 214,559 Valuation Allowance (1,936,367 ) (1,332,037 ) Total Deferred Tax Assets $ 184,379 $ 160,133 Deferred Tax Liabilities Property and equipment $ 24 $ (252 ) Intangible Assets (31,881 ) (561 ) Prepaid Expenses (13,288 ) (35,515 ) ASC 842 Right of Use Asset (139,234 ) (123,805 ) Valuation Allowance - - Total Deferred Tax Liabilities $ (184,379 ) $ (160,133 ) Net Deferred Tax Asset (Liability) $ - $ - In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. As of June 30, 2024, the Company recognized a full valuation allowance on its net deferred tax asset to reflect the fact it is not more-likely-than-not to realize any portion of the asset. Years Ended 6/30/2024 6/30/2023 Other Items – All Gross Federal NOL Carryovers $ 2,715,784 $ 808,741 State NOL Carryovers $ 2,715,784 $ 808,741 At June 30, 2024 and 2023, the Company had net operating loss carryforwards for Federal income tax purposes of $2,715,784 and $808,741, respectively, which would be available to offset future federal taxable income, if any, and would not be subset to expiration. At June 30, 2024 and 2023, the Company has net operating loss carryforwards for state income tax purposes of $2,715,784 and $808,741, which are available to offset future state taxable income, which is subject to expiration beginning in 2043.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jun. 30, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	16. Commitments and Contingencies Legal Proceedings From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. The Company is aware of one legal claim and has accrued approximately $108,000 for such claim (Note 17). The Company is currently not aware of any other such legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition or operating results. Retirement Plans The Successor does not maintain a defined contribution plan or any other type of retirement plan for its employees. For the period of July 1, 2022 through October 16, 2022, the Predecessor maintained a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. Matching contributions to the 401(k) plan are made for certain eligible employees to meet the non- discrimination provisions of the plan. During this period, the Predecessor made a contribution of $1,512. Leases The Company has a non-cancellable operating lease commitment for its office facility expiring in 2028. Rent expense totaled $130,723 and $57,626 for the years ended June 30, 2024 and 2023, respectively. The following table discloses the lease cost, discount rate, and remaining lease term for operating leases as of June 30, 2024 and 2023: June 30, June 30, Operating lease cost $ 130,723 $ 57,626 Remaining lease term 3.7 years 4.7 years Discount rate 6.56 % 6.00 % The discount rate was determined using the Company’s external debt and was adjusted for collateralization, term and lease amount. The following table discloses the undiscounted cash flows on an annual basis and a reconciliation of the undiscounted cash flows of operating lease liabilities recognized in the balance sheet as of June 30, 2024: Year Ended June 30, 2025 $ 163,147 2026 167,226 2027 171,407 2028 116,160 2029 - Total undiscounted cash flows 617,940 Less amount representing interest (67,949 ) Present value of lease liabilities 549,991 Less current portion (131,887 ) Noncurrent lease liabilities $ 418,104

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events The Company has evaluated events subsequent to June 30, 2024, to assess the need for potential recognition or disclosure. Such events were evaluated through September 20, 2024, the date the financial statements were available to be issued. The following were noted: Lawsuit On August 20, 2024, the Company’s former Chief Executive Officer, Matthew Atkinson, filed a lawsuit against the Company in the State of Nebraska claiming compensation, unreimbursed expenses and accrued and unpaid vacation owed to him prior to his resignation in February 2024. The Company has accrued approximately $108,000 for such claim (see Note 16). Product Development Proposal On August 20, 2024, the Company entered into a product development proposal with E-Business International Incorporation, pursuant to which Business International Incorporation, an engineering company, will look for more efficient ways to assemble some of the Company’s units, and will then take over assembly of certain products using overseas facilities. Distributor Agreement On September 10, 2024, the Company entered into a sole distributorship agreement with Consensus B.V., pursuant to which Consensus B.V. will act as sole distributor of the Company’s products in the European Union, United Kingdom, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates. The agreement is for a term of five years and may be terminated by either party upon not less than four months’ notice; provided that either party may terminate the agreement immediately upon a substantial breach of the agreement, as more particularly described in the agreement.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024
Pay vs Performance Disclosure
Net Income (Loss)	$ (320,064)	$ (5,023,207)	$ (2,281,742)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The financial statements of the Company (Successor) are presented since the date of acquisition (October 17, 2022) through the period ended June 30, 2023. The results of the Predecessor represent the combined financial statements of the accounts of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC. These combined financial statements include the accompanying combined statements of operation, combined statement of members’ equity and combined statement of cash flows for the period July 1, 2022 through October 16, 2022. All intercompany balances and transactions among the combined entities have been eliminated. In the opinion of predecessor management, all adjustments considered necessary for a fair presentation have been included.
Use of Estimates	Use of Estimates The preparation of the Company’s and Predecessor’s financial statements require management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure in the Company’s combined financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates. Significant estimates and assumptions made by the Company are allowance for bad debt, useful lives of fixed assets, warranty liabilities, accrued contingent liabilities, and allowance for inventory obsolescence.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to a number of risks similar to other early-stage companies including, but not limited to, profitability, the need for additional financing to achieve its business strategy, ability to obtain regulatory approval, significant competition, and dependence on key individuals.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash consists of cash in readily available checking and money market accounts. Cash is recorded at cost, which approximates fair value. As of June 30, 2024 and 2023, cash balances were deposited at a major financial institution. Cash balances are subject to minimal credit risk as the balances are with high credit quality financial institutions.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist of cash. The Company maintains deposits in federally insured financial institutions in excess of respective insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. Major Customers The Company had one customer that accounted for of 14% of its revenues for the year ended June 30, 2024 and two customers that accounted for a total 66% of revenue for the year ended June 30, 2023. Collateral is not required for customer accounts receivable balances. The Company maintains an allowance for doubtful accounts as described in “Accounts Receivable” below. The Company had two customers that accounted for 28% each of total accounts receivable at June 30, 2024, and two customers that accounted for 43% and 12%, respectively, of total accounts receivable at June 30, 2023. Major Vendors The Company has one vendor each that it exclusively purchases a major component of its two main products. The Company expects to maintain this relationship with the vendor; however, it does have a contingency plan in place to use other vendors if necessary, which would result in minor production delays.
Accounts Receivable	Accounts Receivable Accounts receivable is comprised of trade accounts receivables from the Company’s customers. Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company established an allowance for bad debt of accounts receivables based on a percentage assigned to aged days outstanding categories. The Predecessor established the allowance for bad debt based on various factors including credit profiles of the Company’s customers, historical payments, outstanding balances and current economic trends, and performed this analysis periodically. The Company recorded an allowance for doubtful accounts of $2,535 and $4,419 as of June 30, 2024 and 2023, respectively.
Inventory	Inventory Inventory consists of parts, work in progress and finished goods. The Company values parts and finished goods at the lower of the actual costs or net realizable value. The Company values work in progress at cost. The Company periodically reviews inventory for obsolete and potentially impaired items. As of June 30, 2024 and 2023, the Company had an allowance for inventory obsolescence of $14,791 and $14,940, respectively.
Leases	Leases The Company accounts for leases in accordance with ASC Topic 842 (Topic 842), Leases Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, and probable amounts the lessee will owe under a residual value guarantee. Variable lease payments are recognized as lease expenses as incurred, and generally relate to variable payments made based on the level of services provided by the landlords of our leases. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term within general and administrative expenses in the statement of operations. The Company uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments because the Company does not have the information necessary to determine the rate implicit in the lease. The Company’s lease term includes any option to extend the lease when it is reasonably certain to be exercised based on consideration of all relevant factors. Leases with an initial term of 12 months or less are not recorded on the balance sheets and the Company recognizes lease expense for these leases on a straight-line basis over the lease term.
Business Combinations	Business Combinations Business combinations are accounted for using the acquisition method. The fair value of total purchase consideration is allocated to the fair values of identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount being classified as goodwill. All assets, liabilities and contingent liabilities acquired or assumed in a business combination are recorded at their fair values at the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Estimates of fair value are based on assumptions believed to be reasonable, but are inherently uncertain and unpredictable and, as a result, actual results may differ from those estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in the statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s statements of operations.
Intangible Assets	Intangible Assets Intangible assets primarily consist of existing technology, customer relationships, and trademarks obtained as a result of the acquisition on October 17, 2022. Intangible assets with definite lives are amortized based on their pattern of economic benefit over their estimated useful lives and reviewed periodically for impairment. The Company’s trademarks are deemed to have an indefinite life. The estimated useful life of the acquired technology is 15 years while the estimated useful life of the customer relationships is 5 years.
Intangible Assets	Impairment of Goodwill The Company evaluates goodwill for impairment annually, as of June 30, or more frequently when indicators of impairment exist. The Company considers qualitative factors including market conditions, legal factors, operating performance indicators, and competition, among others, to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount, including goodwill. If the Company concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company performs a quantitative impairment test. In performing the quantitative impairment test, the Company compares the fair value of its reporting unit to the carrying amount including the goodwill of the reporting unit. If the carrying value, including goodwill, exceeds the reporting unit’s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company performed its annual evaluation of goodwill on June 30, 2024. Based on the analysis, the Company did not recognize an impairment loss during the year ended June 30, 2024. Subsequent evaluations will be performed annually on June 30, per the Company’s policy.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets consist primarily of property and equipment and intangible assets. Long-lived assets are tested for impairment when events and circumstances indicate the assets might be impaired by first comparing the estimated future undiscounted cash flows of the asset or asset group to the carrying value. If the carrying value exceeds the estimated future undiscounted cash flows, an impairment loss is recognized based on the amount that the carrying value exceeds the fair value of the asset or asset group. The Company did not recognize impairment losses during the periods ended June 30, 2024 and 2023.
Deferred Offering Costs	Deferred Offering Costs In accordance with ASC 340-10-S99-1 and SEC Accounting Bulletin Topic 5A, specific incremental costs incurred by the Company directly attributable to a proposed offering of securities were deferred. As the initial public offering closed on April 30, 2024, a total of $890,453 deferred costs were charged against the gross proceeds of the offering for the year ended June 30, 2024. These offering costs included fees paid to underwriters, attorney, accountants as well as printers and other third parties directly related to the offering. Costs such as management salaries or other general administrative expenses that are not incremental to the offering are not included in the deferred costs.
Patent Costs	Patent Costs Costs related to filing and pursuing patent applications are expensed as incurred, as recoverability of such expenditures is uncertain. These costs are included in general and administrative expenses.
Advertising Costs	Advertising Costs The Company reports as expense the cost of advertising and promoting its services as incurred. Such amounts totaled $116,007 for the year ended June 30, 2024, and $4,621 and $14,944 for the period and year ended October 16, 2022 and June 30, 2023, respectively.
Stock-based Compensation	Stock-based Compensation Compensation expense is recognized for all share-based payments to employees and nonemployees, including stock options, restricted stock awards, and warrants, in the statements of operation based on the fair value of the awards that are granted. As necessary, the Company’s stock price at the date of grant was estimated using an acceptable valuation technique such as the probability-weighted expected return model. The fair value of stock options and warrants are estimated at the date of grant using the Black-Scholes option-pricing model. The fair value of restricted stock awards is based on the fair market value of the Company’s class B common stock on the date of grant. Compensation expense for restricted stock awards with performance-based vesting conditions is calculated based on the number of awards that are expected to vest during the performance period if it is probable that the performance metrics will be achieved. Generally, measured compensation cost, net of actual forfeitures, is recognized on a straight-line basis over the vesting period of the related share-based compensation award. The Company accounts for forfeitures of stock-based awards as they occur.
Revenue Recognition	Revenue Recognition The Company generates revenues from sales of its products and recognizes revenue as control of its products is transferred to its customers, which is generally at the time of shipment based on the contractual terms with the Company’s customers. The Company provides customer programs and incentive offerings, including growth incentives and volume-based incentives. These customer programs and incentives are considered variable consideration. The Company includes in revenue variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the variable consideration is resolved. This determination is made based upon known customer program and incentive offerings at the time of sale and expected sales volume forecasts as it relates to the Company’s volume-based incentives. This determination is updated every reporting period. For the years ended June 30, 2024 and 2023, customer growth and volume-based incentives were minimal. Certain product sales include a 2-year manufacturer’s warranty that provides the customer with assurance that the product performs as intended. Such warranties are assurance-type warranties and are accounted for as contingencies under ASC 460-10. Refer to Note 10 for warranty reserve.
Income Taxes	Income Taxes The Company accounts for income tax on the basis of the tax laws enacted at the balance sheet date in accordance with FASB ASC 740, Income Taxes Tax positions are recognized if it is more-likely-than-not, based on technical merits, that the tax position will be realized or sustained upon examination. The term “more-likely-than-not” means a likelihood of more than 50%; the terms examined and upon examination also include resolution of the related appeals or litigation processes, if any. A tax position that meets the more-likely-than-not recognition threshold is initially and subsequently measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. The determination of whether or not a tax position has met the more-likely-than-not recognition threshold considers the facts, circumstances and information available at the reporting date and is subject to management’s judgment.
Net Loss per Share of Common Stock	Net Loss per Share of Common Stock Basic net loss per class A and class B common share is calculated by dividing the net loss distributed to class A and class B, respectively, by the weighted-average number of common shares of each respective class outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants are considered to be potentially dilutive securities. As of June 30, 2024 and 2023, there were 3,382,500 and 2,816,263, respectively, of potential common stock equivalents excluded from the diluted loss per share calculations as their effect is anti-dilutive. Because the Company has reported a net loss for the years ended June 30, 2024 and 2023, diluted net loss per common share is the same as basic net loss per common share for such years.
New Accounting Pronouncements	New Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires greater disaggregation of income tax disclosures related to the income tax rate reconciliation and income taxes paid and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued. The amendments should be applied on a prospective basis although retrospective application is permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance in this update is effective for all public entities for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures.

Disaggregated Revenue (Tables)

Disaggregated Revenue (Tables)	12 Months Ended
	Jun. 30, 2024
Disaggregated Revenue [Abstract]
Schedule of Disaggregates Revenue	The following table disaggregates revenue by product category for the following periods ended: Year Ended October 17, July 1, Janitorial & Sanitation $ 1,518,079 $ 1,732,611 $ 369,089 Ice System 19,495 30,195 16,744 Commercial and Residential Laundry 21,129 5,016 6,444 Sanitizing & Disinfecting Tablets - 3,140 160 Other 46,270 167,404 110,553 Total revenue $ 1,604,973 $ 1,938,366 $ 502,990

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	12 Months Ended
	Jun. 30, 2024
Accounts Receivable, Net [Abstract]
Schedule of Accounts Receivable, Net	Accounts receivable, net consists of the following at: June 30, June 30, Trade accounts receivable $ 469,821 $ 237,979 Allowance for doubtful accounts (2,535 ) (4,419 ) Total accounts receivable, net $ 467,286 $ 233,560

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Jun. 30, 2024
Business Combinations [Abstract]
Schedule of Fair Value of Assets Acquired and Liabilities Assumed	The following table summarizes the fair value of the consideration paid and the fair value of assets acquired and liabilities assumed on October 17, 2022, the acquisition date. Consideration Total payments at closing $ 2,000,000 Note payable to seller at fair value 2,982,000 Contingent consideration at fair value - Fair value of total consideration $ 4,982,000 Recognized amounts of identifiable assets acquired and liabilities assumed Accounts receivable $ 134,259 Inventory 1,204,023 Prepaids assets 5,543 Existing technology 600,000 Customer relationships 570,000 Tradenames/trademarks 580,000 Accounts payable and current liabilities (349,735 ) Total identifiable net assets $ 2,744,090 Goodwill 2,237,910 $ 4,982,000

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Jun. 30, 2024
Inventory [Abstract]
Schedule of Inventory	Inventory consists of the following at: June 30, June 30, Parts $ 503,004 $ 551,264 Finished goods 184,112 135,792 Inventory reserve (14,790 ) (14,940 ) Total inventory, net $ 672,326 $ 672,116

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Jun. 30, 2024
Property and Equipment, Net [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net, consist of the following at: June 30, June 30, Equipment $ 8,217 $ - Vehicles - - Furniture and fixtures - - Leasehold improvements 3,481 1,260 Total 11,698 1,260 Less: accumulated depreciation (1,126 ) (63 ) Total property and equipment, net $ 10,572 $ 1,197

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following at: June 30, June 30, Technology $ 600,000 $ 600,000 Customer relationships 570,000 570,000 Trademarks 580,000 580,000 Total 1,750,000 1,750,000 Less: accumulated amortization (263,077 ) (109,081 ) Total intangible assets, net $ 1,486,923 $ 1,640,919

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Jun. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consist of the following at: June 30, June 30, Accounts payable $ 176,077 $ 266,511 Accrued interest 23,113 152,684 Accrued payroll and related expenses 59,943 68,026 Accrued pending litigation (Note 17) 108,242 - Warranty reserve 96,636 156,333 Accrued severance 70,000 - Other accrued expenses 39,945 1,073 Total accounts payable and other accrued expenses $ 573,956 $ 644,627

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Schedule of Due To Related Party Balances Were Outstanding	The following due to related party balances were outstanding at: June 30, June 30, Due to founder – credit card $ 91,119 $ 12,402 Due to founders - 208,900 Total due to related parties $ 91,119 $ 221,302

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2024
Stockholders’ Equity [Abstract]
Schedule of Awards Granted and Outstanding	The information presented in the following table represents the restricted stock awards, including performance-based awards, granted and outstanding during the period: Performance- Service-Based Weighted Beginning balance - - $ - Granted - - - Forfeited - - - Vested - - - Outstanding, unvested grants at June 30, 2023 - - - Granted 235,000 - 3.10 Granted - 1,448,000 3.10 Forfeited - (1,212,500 ) 3.10 Vested - (107,500 ) 3.10 Outstanding, unvested grants at June 30, 2024 235,000 128,000 $ 3.09
Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model	The fair value of stock options and warrants was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted average assumptions for the years ended June 30, 2024 and 2023: June 30, June 30, Risk-free interest rate 5.10 % 3.80 % Dividend yield 0.0 % 0.0 % Expected volatility 47.44 % 54.04 % Expected life of awards 3.3 years 3.9 years Fair value of awards granted during the year $ 0.90 $ 1.35
Schedule of Weighted-Average Fair Value Per Share of Total Awards	The weighted-average fair value per share of total awards granted during the years ended June 30, 2024 and 2023 was $1.35 and $0.90, respectively. Warrants Stock Weighted Weighted Beginning balance - - - $ - Granted 824,041 - 0.44 0.69 Granted - 2,770,000 4.77 0.51 Cancelled - - - - Forfeited - - - - Exercised (777,778 ) - - 0.61 Outstanding, June 30, 2023 (2,125,152 shares exercisable) 46,263 2,770,000 5.01 $ 0.59 Granted - 525,000 2.44 3.31 Granted 87,500 0.86 0.86 Cancelled (46,263 ) - 0.08 Forfeited - - - - Exercised - - - - Outstanding, June 30, 2024 (2,738,472 shares exercisable) 87,500 3,295,000 3.30 $ 4.17

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	12 Months Ended
	Jun. 30, 2024
Net Loss Per Share [Abstract]
Schedule of Basic and Dilutive Net Income Per Share of Common Stock	The following table sets forth the computation of basic and dilutive net income per share of class A and class B common stock: Year Ended June 30, 2024 Class A Class B Basic and diluted net loss per share: Numerator Allocation of undistributed loss $ (171,420 ) $ (2,110,322 ) Denominator Weighted average number of shares used in per share computation 350,192 4,311,142 Basic and diluted net loss per share $ (0.49 ) $ (0.49 ) Period Ended June 30, 2023 (Successor) Class A Class B Basic and diluted net loss per share: Numerator Allocation of undistributed loss $ (2,111,882 ) $ (2,911,325 ) Denominator Weighted average number of shares used in per share computation 967,987 1,334,414 Basic and diluted net loss per share $ (2.18 ) $ (2.18 )

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2024
Income Taxes [Abstract]
Schedule of Pre-Tax Book Income	The Company’s provision for income taxes is comprised of the following components for the year ended June 30, 2024: Years Ended 6/30/2024 6/30/2023 Current Tax Expense (Benefit) Federal - - State - - Current Tax Expense (Benefit) $ - $ - Deferred Tax Expense (Benefit) Federal - - State - - Deferred Tax Expense (Benefit) - - Total Income Tax Expense (Benefit) $ - $ -
Schedule of Pre-Tax Book Income	The Company’s income tax expense from continuing operations for the year ended June 30, 2024 differed from the statutory federal rate of 21% as follows: Pre-Tax Book Income $ (2,281,742 )
Schedule of Income Tax Expense from Continuing Operations	Years Ended 6/30/2024 6/30/2023 Amount Percent Amount Percent Rate Reconciliation Federal tax (benefit) at a statutory rate $ (479,166 ) 21 % $ (1,054,873 ) 21.00 % State tax expense (benefit) (125,968 ) 5.52 % (277,654 ) 5.53 % Other Permanent Differences 804 (0.04 )% 490 (0.01 )% Increase (Decrease) in valuation allowance related to current period P&L activity 604,330 (26.49 )% 1,332,037 (26.52 )% Total tax expense $ - 0.00 % $ - 0.00 %
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities consist of the following at June 30, 2024: Years Ended 6/30/2024 6/30/2023 Deferred Tax Assets Accrued Expenses $ 67,775 $ 55,680 Equity Compensation 1,186,561 1,092,856 Lease Liabilities 145,913 129,075 NOL Carryforwards 720,498 214,559 Valuation Allowance (1,936,367 ) (1,332,037 ) Total Deferred Tax Assets $ 184,379 $ 160,133 Deferred Tax Liabilities Property and equipment $ 24 $ (252 ) Intangible Assets (31,881 ) (561 ) Prepaid Expenses (13,288 ) (35,515 ) ASC 842 Right of Use Asset (139,234 ) (123,805 ) Valuation Allowance - - Total Deferred Tax Liabilities $ (184,379 ) $ (160,133 ) Net Deferred Tax Asset (Liability) $ - $ -
Schedule of Company Recognized a Full Valuation Allowance on its Net Deferred Tax Asset	As of June 30, 2024, the Company recognized a full valuation allowance on its net deferred tax asset to reflect the fact it is not more-likely-than-not to realize any portion of the asset. Years Ended 6/30/2024 6/30/2023 Other Items – All Gross Federal NOL Carryovers $ 2,715,784 $ 808,741 State NOL Carryovers $ 2,715,784 $ 808,741

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Jun. 30, 2024
Commitments and Contingencies [Abstract]
Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases	The following table discloses the lease cost, discount rate, and remaining lease term for operating leases as of June 30, 2024 and 2023: June 30, June 30, Operating lease cost $ 130,723 $ 57,626 Remaining lease term 3.7 years 4.7 years Discount rate 6.56 % 6.00 %
Schedule of Undiscounted Cash Flows	The following table discloses the undiscounted cash flows on an annual basis and a reconciliation of the undiscounted cash flows of operating lease liabilities recognized in the balance sheet as of June 30, 2024: Year Ended June 30, 2025 $ 163,147 2026 167,226 2027 171,407 2028 116,160 2029 - Total undiscounted cash flows 617,940 Less amount representing interest (67,949 ) Present value of lease liabilities 549,991 Less current portion (131,887 ) Noncurrent lease liabilities $ 418,104

Organization and Business (Deta

Organization and Business (Details) - USD ($)		4 Months Ended	8 Months Ended	12 Months Ended
	Apr. 30, 2024	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024
Organization and Business [Line Items]
Gross offering proceeds				$ 4,233,875
Cash			$ 393,194	2,016,611
Net loss		$ (320,064)	$ (5,023,207)	(2,281,742)
Cash used for operating activities				(1,547,880)
IPO [Member]
Organization and Business [Line Items]
Issuance of common stock (in Shares)	1,250,000
Common stock price per share (in Dollars per share)	$ 4
Gross offering proceeds	$ 50,000,000
Net proceeds				$ 3,343,547

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Apr. 30, 2024
Summary of Significant Accounting Policies [Line Items]
Allowance for doubtful accounts		$ 4,419	$ 2,535	$ 4,419
Deferred costs					$ 890,453
Advertising cost	$ 4,621	14,944	$ 116,007
Tax position			50%
Percentage of litigation processes			(0.04%)	(0.01%)
Acquired Technology [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful life			15 years
Customer Relationships [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful life			5 years
Management’s Judgment [Member]
Summary of Significant Accounting Policies [Line Items]
Percentage of litigation processes			50%
Inventory Valuation and Obsolescence [Member]
Summary of Significant Accounting Policies [Line Items]
Allowance for inventory obsolescence		14,940	$ 14,791	$ 14,940
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Anti dilutive share (in Shares)			3,382,500	2,816,263
Predecessor [Member]
Summary of Significant Accounting Policies [Line Items]
Advertising cost	$ 4,621
Successor [Member]
Summary of Significant Accounting Policies [Line Items]
Advertising cost		$ 14,944
One Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Summary of Significant Accounting Policies [Line Items]
Customer percentage			14%
One Customer [Member] | Customer Concentration Risk [Member] | Trade Accounts Receivable [Member]
Summary of Significant Accounting Policies [Line Items]
Customer percentage				43%
Two Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Summary of Significant Accounting Policies [Line Items]
Customer percentage				66%
Two Customer [Member] | Customer Concentration Risk [Member] | Trade Accounts Receivable [Member]
Summary of Significant Accounting Policies [Line Items]
Customer percentage			28%	12%

Disaggregated Revenue (Details)

Disaggregated Revenue (Details) - Schedule of Disaggregates Revenue - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024
Schedule of Disaggregates Revenue [Line Items]
Total revenue	$ 502,990	$ 1,938,366	$ 1,604,973
Janitorial and Sanitation [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	369,089	1,732,611	1,518,079
Ice System [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	16,744	30,195	19,495
Commercial and Residential Laundry [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	6,444	5,016	21,129
Sanitizing & Disinfecting Tablets [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	160	3,140
Other [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	$ 110,553	$ 167,404	$ 46,270

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - Schedule of Accounts Receivable, Net - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Schedule of Accounts Receivable, Net [Abstract]
Trade accounts receivable	$ 469,821	$ 237,979
Allowance for doubtful accounts	(2,535)	(4,419)
Total accounts receivable, net	$ 467,286	$ 233,560

Business Combinations (Details)

Business Combinations (Details) - USD ($)		12 Months Ended
	Oct. 17, 2022	Jun. 30, 2023	Jun. 30, 2024
Business Combinations [Line Items]
Bearing interest rate	7%
Purchase price	$ 500,000
Contingent consideration	0
Goodwill	2,237,910	$ 2,237,910	$ 2,237,910
Business Combinations [Member]
Business Combinations [Line Items]
Total consideration	2,000,000
Note payable	$ 3,000,000
General and Administrative Expense [Member]
Business Combinations [Line Items]
Acquisition-related costs		$ 31,676

Business Combinations (Detail_2

Business Combinations (Details) - Schedule of Fair Value of Assets Acquired and Liabilities Assumed - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Oct. 17, 2022
Consideration
Total payments at closing			$ 2,000,000
Note payable to seller at fair value			2,982,000
Contingent consideration at fair value
Fair value of total consideration			4,982,000
Recognized amounts of identifiable assets acquired and liabilities assumed
Accounts receivable			134,259
Inventory			1,204,023
Prepaids assets			5,543
Existing technology			600,000
Customer relationships			570,000
Tradenames/trademarks			580,000
Accounts payable and current liabilities			(349,735)
Total identifiable net assets			2,744,090
Goodwill	$ 2,237,910	$ 2,237,910	2,237,910
Fair value of total consideration			$ 4,982,000

Inventory (Details)

Inventory (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Inventory [Abstract]
Inventory reserve	$ 14,790	$ 14,940

Inventory (Details) - Schedule

Inventory (Details) - Schedule of Inventory - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Inventory [Abstract]
Parts	$ 503,004	$ 551,264
Finished goods	184,112	135,792
Inventory reserve	(14,790)	(14,940)
Total inventory, net	$ 672,326	$ 672,116

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Property and Equipment, Net [Abstract]
Depreciation expense	$ 1,063	$ 63

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Line Items]
Total	$ 11,698	$ 1,260
Less: accumulated depreciation	(1,126)	(63)
Total property and equipment, net	10,572	1,197
Equipment [Member]
Property, Plant and Equipment [Line Items]
Total	8,217
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Total
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Total
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Total	$ 3,481	$ 1,260

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Intangible Assets [Abstract]
Amortization expense	$ 153,996	$ 109,081

Intangible Assets (Details) - S

Intangible Assets (Details) - Schedule of Intangible Assets - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Schedule of Intangible Assets [Line Items]
Intangible assets, Gross	$ 1,750,000	$ 1,750,000
Less: accumulated amortization	(263,077)	(109,081)
Total intangible assets, net	1,486,923	1,640,919
Technology [Member]
Schedule of Intangible Assets [Line Items]
Intangible assets, Gross	600,000	600,000
Customer Relationships [Member]
Schedule of Intangible Assets [Line Items]
Intangible assets, Gross	570,000	570,000
Trademarks [Member]
Schedule of Intangible Assets [Line Items]
Intangible assets, Gross	$ 580,000	$ 580,000

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Schedule of Accounts Payable and Accrued Expenses [Abstract]
Accounts payable	$ 176,077	$ 266,511
Accrued interest	23,113	152,684
Accrued payroll and related expenses	59,943	68,026
Accrued pending litigation	108,242
Warranty reserve	96,636	156,333
Accrued severance	70,000
Other accrued expenses	39,945	1,073
Total accounts payable and other accrued expenses	$ 573,956	$ 644,627

Debt (Details)

Debt (Details) - USD ($)						1 Months Ended	12 Months Ended
	Jun. 28, 2024	May 31, 2024	May 02, 2024	Apr. 30, 2024	Oct. 17, 2022	Mar. 26, 2024	Jun. 30, 2024	Jan. 30, 2024	Sep. 13, 2023
Debt [Line Items]
Outstanding principal balance						$ 500,000
Transfer amount		$ 633,840
Paid amount		900,000
Principal amount		480,667	$ 225,000
Accrued interest amount		419,333
Original issue discount percentage					8.50%
Accrues interest percent increase					10%
Annual payment due		$ 1,396,881			$ 100,000
Debt Instrument due date					Dec. 31, 2024
Conversion of common stock (in Shares)			257,479
Burlington Promissory Note [Member]
Debt [Line Items]
Outstanding principal balance					$ 3,000,000
Interest rate					7%				10%
Maturity date		Apr. 01, 2027		May 09, 2024	Oct. 17, 2023
Quarterly payment due		$ 2,366,160
Original issue discount percentage					8.50%
Outstanding principal balance							$ 633,840
Burlington and Walker Water LLC [Member]
Debt [Line Items]
Accrues interest percent increase					10%
Outstanding principal balance							1,885,493
Promissory Note [Member]
Debt [Line Items]
Outstanding principal balance							633,840
Convertible Promissory Notes [Member]
Debt [Line Items]
Original issue discount percentage								10%
Separate Accredited Investors One [Member]
Debt [Line Items]
Principal amount								$ 27,778
Purchase prices of notes payable								25,000
Separate Accredited Investors Two [Member]
Debt [Line Items]
Principal amount								111,111
Purchase prices of notes payable								100,000
Separate Accredited Investors Three [Member]
Debt [Line Items]
Principal amount								111,111
Purchase prices of notes payable								$ 100,000
Revolving Credit Facility [Member]
Debt [Line Items]
Loan agreement	$ 100,000
Convertible Promissory Notes [Member]
Debt [Line Items]
Interest rate								12%
Accrued interest amount			$ 37,479
Burlington and Walker Water LLC [Member]
Debt [Line Items]
Accrued interest amount							13,673
Burlington Promissory Note [Member]
Debt [Line Items]
Accrued interest amount							$ 4,490

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)						1 Months Ended	12 Months Ended
	May 31, 2024	May 29, 2024	Apr. 01, 2024	Oct. 17, 2022	Oct. 04, 2022	Mar. 26, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Jul. 27, 2023
Related Party Transactions [Line Items]
Principal amount						$ 500,000
Bear interest rate				7%
Accrued interest	$ 419,333
Repaid accrued interest		$ 8,506
Birddog monthly fee			$ 22,000	$ 6,000
Initial public offering							$ 4,233,875
Restricted stock unit (in Shares)			500,000
Share vesting (in Shares)			250,000
Inventory							672,326	$ 672,116
Interest rate						8%			7%
Accrued interest							2,471
Interest rate increase				10%
Matthew Atkinson [Member]
Related Party Transactions [Line Items]
Amount of operational expenses					$ 208,900
Accrued interest								7,698
Nebraska C. Ozone, LLC [Member]
Related Party Transactions [Line Items]
Inventory									$ 105,000	$ 105,000
Clayton Adams [Member]
Related Party Transactions [Line Items]
Amount of operational expenses							91,119
Principal amount							$ 0
Interest rate increase						13%
Birddog Capital, LLC (“Birddog”) [Member]
Related Party Transactions [Line Items]
Initial public offering			$ 175,000
Share vesting (in Shares)			250,000
Elev8 [Member]
Related Party Transactions [Line Items]
Birddog monthly fee				$ 6,000
Chief Executive Officer [Member]
Related Party Transactions [Line Items]
Principal amount					$ 104,450
Chief Executive Officer [Member]
Related Party Transactions [Line Items]
Amount of operational expenses								$ 12,402
Bear interest rate					5%

Related Party Transactions (D_2

Related Party Transactions (Details) - Schedule of Due To Related Party Balances Were Outstanding - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Founders [Member]
Schedule of Due To Related Party Balances Were Outstanding [Line Items]
Total due to related parties		$ 208,900
Related Party [Member]
Schedule of Due To Related Party Balances Were Outstanding [Line Items]
Total due to related parties	91,119	221,302
Founder – Credit Card [Member]
Schedule of Due To Related Party Balances Were Outstanding [Line Items]
Total due to related parties	$ 91,119	$ 12,402

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)											1 Months Ended	8 Months Ended	12 Months Ended
	Jul. 12, 2024	Jun. 12, 2024	May 15, 2024	May 02, 2024	Apr. 30, 2024	Feb. 29, 2024	Feb. 06, 2024	Jan. 03, 2024	Jun. 01, 2023	Apr. 01, 2023	Jul. 31, 2023	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Nov. 30, 2022	Nov. 29, 2022	Nov. 18, 2022	Oct. 31, 2022	Oct. 17, 2022	Oct. 14, 2022	Sep. 30, 2022	Aug. 26, 2022	Jun. 30, 2022
Stockholders’ Equity [Line Items]
Preferred Stock authorized												4,000,000	4,000,000	4,000,000
Preferred Stock, par value (in Dollars per share)												$ 0.0001	$ 0.0001	$ 0.0001
Voting rights													one
Conversion price (in Dollars per share)													$ 0.25
Preferred stock, shares issued and outstanding												4,000,000	0	4,000,000
Aggregate exercise price (in Dollars)					$ 5														$ 500,000
Purchase price per share (in Dollars per share)										$ 1.74
Total stock compensation expense (in Dollars)										$ 29,999
Common stock proceeds (in Dollars)													$ 3,343,547
Common stock net (in Dollars)					$ 1,656,453								$ 1,656,453
Weighted average exercise price (in Dollars per share)												$ 0.59	$ 4.17	$ 0.59
Purchase of shares					87,500
Vested number of shares	5,000	5,000			87,500								18,000
Warrants exercise price (in Dollars per share)													$ 1.74
Remaining shares					75,000
Vested and forfeited shares					87,500
share issued (in Dollars)					$ 87,500							$ 149,433	$ 172,853
Vest shares													160,000
Weighted-average fair value of total awards granted (in Dollars per share)													$ 0.9	$ 1.35
Share based compensation (in Dollars)													$ 670,958
Total unrecognized stock compensation expense (in Dollars)													$ 930,433
Expected term													3 years 3 months 18 days	3 years 10 months 24 days
Warrant [Member]
Stockholders’ Equity [Line Items]
Warrants issued (in Dollars)													$ 42,835
Liquidation Rights [Member]
Stockholders’ Equity [Line Items]
Dividends per share (in Dollars per share)													$ 0.25
Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock authorized													350,000,000
Common stock, shares issued													300,000,000
Conversion of shares													4,000,000
Share based compensation (in Dollars)													$ 670,958
Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred Stock authorized													50,000,000
Stock-based Compensation [Member]
Stockholders’ Equity [Line Items]
Weighted-average fair value of total awards granted (in Dollars per share)													$ 1.35	$ 0.9
Warrant [Member]
Stockholders’ Equity [Line Items]
warrant issued (in Dollars)														$ 857,889
Warrant [Member]
Stockholders’ Equity [Line Items]
Percentage of total number of shares of common stock issued and outstanding								5%
Expected term													2 years 3 days
Stock Options [Member]
Stockholders’ Equity [Line Items]
Share based compensation (in Dollars)														$ 3,231,443
Class A Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock authorized												50,000,000	50,000,000	50,000,000
Common stock, shares issued												660,000	270,000	660,000
Common stock, par value (in Dollars per share)												$ 0.0001	$ 0.0001	$ 0.0001
Purchase price per share (in Dollars per share)																						$ 0.0001
Aggregate shares were converted									340,000
Common stock, shares outstanding												660,000	270,000	660,000
Weighted average exercise price (in Dollars per share)													$ 0.25
Exercise price (in Dollars per share)													3.31
Class A Common Stock [Member] | Conversion Rights [Member]
Stockholders’ Equity [Line Items]
Dividends per share (in Dollars per share)													$ 0.25
Class A Common Stock [Member] | Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued				257,479		2,000,000					1,000,000		660,000									1,000,000
Conversion of shares												(340,000)	(4,390,000)
Common stock, shares outstanding													660,000
Shares of common stock													4,000,000
Common stock proceeds (in Dollars)
share issued (in Dollars)
Class A Common Stock [Member] | Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Conversion of shares					1,000,000
Class A Common Stock [Member] | Stock Options [Member]
Stockholders’ Equity [Line Items]
Shares available for grant													2,000,000
Purchase of shares													525,000
Class A Common Stock [Member] | Convertion Shares [Member]
Stockholders’ Equity [Line Items]
Conversion of shares			880,000				200,000
Class B Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock authorized												250,000,000	250,000,000	250,000,000
Common stock, shares issued											1,310,000	1,795,940	7,960,919	1,795,940
Common stock, par value (in Dollars per share)												$ 0.0001	$ 0.0001	$ 0.0001
Purchase price per share (in Dollars per share)															$ 1.74			$ 1.74
Conversion of shares				225,000		2,000,000					1,310,000
Aggregate shares															660,921			660,921
Aggregate shares were converted									340,000
Common stock, shares outstanding												1,795,940	7,960,919	1,795,940
Shares of common stock					1,250,000
Common stock proceeds (in Dollars)					$ 3,343,547
Common stock restricted					175,000
Restricted stock		5,000			87,500
Accrued interest (in Dollars)				$ 37,479
Shares reserved																	1,736,819
Shares available for grant								3,240,000
Weighted average exercise price (in Dollars per share)													$ 2.21
Vested number of shares					10,625								75,000
Restricted stock unit award (in Dollars)		$ 188,000			$ 1,300,000
share issued (in Dollars)					$ 20,000
Class B Common Stock [Member] | Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued													1,795,940
Conversion of shares												340,000	4,390,000
Common stock, shares outstanding													1,795,940
Common stock proceeds (in Dollars)													$ 125
Common stock restricted					175,000								175,000
share issued (in Dollars)
Class B Common Stock [Member] | Warrant [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued																777,778
Aggregate exercise price (in Dollars)																$ 500,000
Purchase of shares																4,022			777,778	42,241
Class B Common Stock [Member] | Stock Options [Member]
Stockholders’ Equity [Line Items]
Purchase of shares													770,000
Class B Common Stock [Member] | Restricted Stock [Member]
Stockholders’ Equity [Line Items]
Vested number of shares					15,000
Class B Common Stock [Member] | Convertion Shares [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued			880,000				200,000			17,241
Series Seed Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred Stock authorized													4,000,000
Preferred stock, shares issued and outstanding																					4,000,000
Purchase price per share (in Dollars per share)																					$ 0.25
Conversion of shares				10		2,000,000
Series Seed Preferred Stock [Member] | Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares issued and outstanding					1,000,000								4,000,000
Conversion of shares											1,000,000
Series Seed Preferred Stock [Member] | Conversion Rights [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares issued and outstanding												4,000,000		4,000,000
IPO [Member]
Stockholders’ Equity [Line Items]
Dividends per share (in Dollars per share)					$ 4
Shares available for grant					1,250,000
Warrants issued (in Dollars)													$ 94,850

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of Awards Granted and Outstanding - $ / shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Stockholders' Equity (Details) - Schedule of Awards Granted and Outstanding [Line Items]
Weighted Average Grant Date Fair Value, Balance (in Dollars per share)	$ 3.09
Weighted Average Grant Date Fair Value, Granted (in Dollars per share)	3.1
Weighted Average Grant Date Fair Value, Granted (in Dollars per share)	$ 3.1
Restricted Shares, Forfeited
Weighted Average Grant Date Fair Value, Forfeited (in Dollars per share)	$ 3.1
Weighted Average Grant Date Fair Value,Vested (in Dollars per share)	3.1
Weighted Average Grant Date Fair Value, Outstanding (in Dollars per share)	$ 3.09
Performance- Based Restricted Shares [Member]
Stockholders' Equity (Details) - Schedule of Awards Granted and Outstanding [Line Items]
Restricted Shares, Balance
Restricted Shares, Granted	235,000
Restricted Shares, Granted
Restricted Shares, Forfeited
Restricted Shares, Vested
Restricted Shares, Outstanding	235,000
Service-Based Restricted Shares [Member]
Stockholders' Equity (Details) - Schedule of Awards Granted and Outstanding [Line Items]
Restricted Shares, Balance
Restricted Shares, Granted
Restricted Shares, Granted	1,448,000
Restricted Shares, Forfeited	(1,212,500)
Restricted Shares, Vested	(107,500)
Restricted Shares, Outstanding	128,000

Stockholders' Equity (Details_2

Stockholders' Equity (Details) - Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model - $ / shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model [Abstract]
Risk-free interest rate	5.10%	3.80%
Dividend yield	0%	0%
Expected volatility	47.44%	54.04%
Expected life of awards	3 years 3 months 18 days	3 years 10 months 24 days
Fair value of awards granted during the year (in Dollars per share)	$ 0.9	$ 1.35

Stockholders' Equity (Details_3

Stockholders' Equity (Details) - Schedule of Weighted-Average Fair Value Per Share of Total Awards - $ / shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Weighted-Average Fair Value Per Share of Total Awards [Abstract]
Warrants, Balance	46,263
Stock Options, Balance	2,770,000
Weighted Average Remaining Life (years), Balance
Weighted Average Exercise Price, Balance (in Dollars per share)	$ 0.59
Warrants, Granted	87,500	824,041
Weighted Average Remaining Life (years), Granted	10 months 9 days	5 months 8 days
Weighted Average Exercise Price, Granted (in Dollars per share)	$ 0.86	$ 0.69
Stock Options, Granted	525,000	2,770,000
Weighted Average Remaining Life (years), Granted One	2 years 5 months 8 days	4 years 9 months 7 days
Weighted Average Exercise Price, Granted One (in Dollars per share)	$ 3.31	$ 0.51
Warrants, Cancelled	(46,263)
Stock Options, Cancelled
Weighted Average Remaining Life (years), Cancelled
Weighted Average Exercise Price, Cancelled (in Dollars per share)	$ 0.08
Warrants, Forfeited
Stock Options, Forfeited
Weighted Average Remaining Life (years), Forfeited
Weighted Average Exercise Price, Forfeited (in Dollars per share)
Warrants, Exercised		(777,778)
Stock Options, Exercised
Weighted Average Remaining Life (years), Exercised
Weighted Average Exercise Price, Exercised (in Dollars per share)		$ 0.61
Warrants, Outstanding	87,500	46,263
Stock Options, Outstanding	3,295,000	2,770,000
Weighted Average Remaining Life (years), Outstanding	3 years 3 months 18 days	5 years 3 days
Weighted Average Exercise Price, Outstanding (in Dollars per share)	$ 4.17	$ 0.59

Stockholders' Equity (Details_4

Stockholders' Equity (Details) - Schedule of Weighted-Average Fair Value Per Share of Total Awards (Parentheticals) - shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Weighted-Average Fair Value Per Share of Total Awards [Abstract]
Stock Options, Shares exercisable	2,738,472	2,125,152

Net Loss Per Share (Details) -

Net Loss Per Share (Details) - Schedule of Basic and Dilutive Net Income Per Share of Common Stock - USD ($)	8 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Class A [Member]
Numerator
Allocation of undistributed loss		$ (171,420)	$ (2,111,882)
Denominator
Weighted average number of shares used in per share computation	967,987	350,192	967,987
Basic net loss per share		$ (0.49)	$ (2.18)
Class B [Member]
Numerator
Allocation of undistributed loss		$ (2,110,322)	$ (2,911,325)
Denominator
Weighted average number of shares used in per share computation	1,334,414	4,311,142	1,334,414
Basic net loss per share		$ (0.49)	$ (2.18)

Net Loss Per Share (Details) _2

Net Loss Per Share (Details) - Schedule of Basic and Dilutive Net Income Per Share of Common Stock (Parentheticals) - $ / shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Class A [Member]
Schedule of Basic and Dilutive Net Income Per Share of Common Stock [Line Items]
Diluted net loss per share	$ (0.49)	$ (2.18)
Class B [Member]
Schedule of Basic and Dilutive Net Income Per Share of Common Stock [Line Items]
Diluted net loss per share	$ (0.49)	$ (2.18)

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Income Taxes [Abstract]
Statutory federal rate	21%	21%
Net operating loss carryforwards for federal income tax	$ 2,715,784	$ 808,741
Net operating loss carryforwards for state income tax	$ 2,715,784	$ 808,741

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of Provision for Income Taxes - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Current Tax Expense (Benefit)
Federal
State
Current Tax Expense (Benefit)
Deferred Tax Expense (Benefit)
Federal
State
Deferred Tax Expense (Benefit)
Total Income Tax Expense (Benefit)

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of Pre-Tax Book Income - USD ($)	4 Months Ended	8 Months Ended	12 Months Ended
	Oct. 16, 2022	Jun. 30, 2023	Jun. 30, 2024
Schedule of Pre-Tax Book Income [Abstract]
Net income (loss)	$ (320,064)	$ (5,023,207)	$ (2,281,742)

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of Income Tax Expense from Continuing Operations - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Income Tax Expense from Continuing Operations [Abstract]
Federal tax (benefit) at a statutory rate, Amount	$ (479,166)	$ (1,054,873)
Federal tax (benefit) at a statutory rate, Percent	21%	21%
State tax expense (benefit), Amount	$ (125,968)	$ (277,654)
State tax expense (benefit), Percent	5.52%	5.53%
Other Permanent Differences, Amount	$ 804	$ 490
Other Permanent Differences, Percent	(0.04%)	(0.01%)
Increase (Decrease) in valuation allowance related to current period P&L activity, Amount	$ 604,330	$ 1,332,037
Increase (Decrease) in valuation allowance related to current period P&L activity, Percent	(26.49%)	(26.52%)
Total Income Tax Expense (Benefit)
Total tax expense, Percent	0%	0%

Income Taxes (Details) - Sche_4

Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Deferred Tax Assets
Accrued Expenses	$ 67,775	$ 55,680
Equity Compensation	1,186,561	1,092,856
Lease Liabilities	145,913	129,075
NOL Carryforwards	720,498	214,559
Valuation Allowance	(1,936,367)	(1,332,037)
Total Deferred Tax Assets	184,379	160,133
Deferred Tax Liabilities
Property and equipment	24	(252)
Intangible Assets	(31,881)	(561)
Prepaid Expenses	(13,288)	(35,515)
ASC 842 Right of Use Asset	(139,234)	(123,805)
Valuation Allowance
Total Deferred Tax Liabilities	(184,379)	(160,133)
Net Deferred Tax Asset (Liability)

Income Taxes (Details) - Sche_5

Income Taxes (Details) - Schedule of Company Recognized a Full Valuation Allowance on its Net Deferred Tax Asset - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Federal NOL Carryovers [Member]
Schedule of Company Recognized a Full Valuation Allowance on its Net Deferred Tax Asset [Line Items
Other Items – All Gross	$ 2,715,784	$ 808,741
State NOL Carryovers [Member]
Schedule of Company Recognized a Full Valuation Allowance on its Net Deferred Tax Asset [Line Items
Other Items – All Gross	$ 2,715,784	$ 808,741

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Commitments and Contingencies [Abstract]
Accrued claim	$ 108,000
Predecessor contribution	1,512
Rent expense	$ 130,723	$ 57,626

Commitments and Contingencies_3

Commitments and Contingencies (Details) - Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases [Abstract]
Operating lease cost	$ 130,723	$ 57,626
Remaining lease term	3 years 8 months 12 days	4 years 8 months 12 days
Discount rate	6.56%	6%

Commitments and Contingencies_4

Commitments and Contingencies (Details) - Schedule of Undiscounted Cash Flows - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Schedule of Undiscounted Cash Flows [Abstract]
2025	$ 163,147
2026	167,226
2027	171,407
2028	116,160
2029
Total undiscounted cash flows	617,940
Less amount representing interest	(67,949)
Present value of lease liabilities	549,991
Less current portion	(131,887)	$ (87,985)
Noncurrent lease liabilities	$ 418,104	$ 398,540

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Sep. 10, 2024	Jun. 30, 2024
Subsequent Events [Abstract]
Accrued claim		$ 108,000
Terminated term	5 years